Prior Authorization Reform for Autoimmune and Blood Disorders Act
Rep. Johnson and Rep. Lawler Introduce Bipartisan Bill to Limit Insurance Paperwork for Chronic Illness Meds
This bill is currently in the early stages of the legislative process and has been sent to three different House committees for review. It is considered active, but no further votes or hearings have been scheduled yet. There is no companion bill currently associated with this legislation.
Legislative Progress
It has support from both parties and addresses a common problem, but it is in the early stages of the lawmaking process and must pass through several committees.
Key Points
Impact Analysis
Personal Impact
Programs
People who buy individual health insurance through ACA marketplace plans would benefit from the new coverage and prior authorization requirements. The bill amends the Public Health Service Act to cover both group and individual health insurance, meaning marketplace enrollees with autoimmune diseases or blood disorders would gain easier access to their medications.
Disabilities
Milestones
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Prior Authorization Reform for Autoimmune and Blood Disorders Act
Data Sources
Sponsor
Cosponsors
(1)Analysis generated by AI. Always verify with official sources.